-
-
-
-
-
-
-
Navidea Biopharma (NAVB) Rejects Unsolicited Offer To Acquire Certain Assets by ProPhase Labs (PRPH)
-
-
-
-
-
-
-
ProPhase Labs to Host 2022 Year End Financial Results Conference Call on Tuesday, March 28, 2023 at 11:00 a.m. Eastern Time
-
-
-
-
-
-
-
ProPhase Labs (PRPH) Announces Plans to Initiate Clinical Trial of Equivir
-
-
-
-
-
-
-
ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
-
-
-
-
-
-
-
ProPhase Labs to Present at Investor Summit Group’s Q4 Conference
-
-
-
-
-
-
-
ProPhase Labs to Present at The ThinkEquity Conference
-
-
-
-
-
-
-
ProPhase Labs Announces Record Second Quarter 2022 Financial Results
-
916,587 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All